发明名称 N-SUBSTITUTED PEPTIDYL NITRILES AS CYSTEINE CATHEPSIN INHIBITORS
摘要 Compounds of the formula (I), wherein R1 is aryl or biaryl; R2 is aryl-lower alkyl, biaryl-lower alkyl, benzo-fused cycloalkyl, cycloalkyl-lower alkyl, bicycloalkyl-lower alkyl, aryloxy-lower alkyl, or aryl-C2-C7-alkyl in which C2-C7-alkyl is interrupted by Y; Y is O, S, SO, SO2, CO or NR6; R3 is hydrogen or lower alkyl; or R2 and R3 combined are C2-C7-alkylene or C2-C7-alkylene interrupted by Y; R4 is hydrogen or lower alkyl; R5 is hydrogen, optionally substituted lower alkyl, aryl-lower alkyl, biaryl-lower alkyl, cycloalkyl-lower alkyl, bicycloalkyl-lower alkyl, arylox y- lower alkyl, or aryl-C2-C7-alkyl in which C2-C7-alkyl is interrupted by Y; R6 is hydrogen, lower alkyl or aryl-lower alkyl; and pharmaceutically acceptable salts thereof, which are useful as cysteine cathepsin inhibitors.
申请公布号 CA2407463(C) 申请公布日期 2010.01.12
申请号 CA20012407463 申请日期 2001.05.14
申请人 NOVARTIS AG 发明人 MCQUIRE, LESLIE WIGHTON;COWEN, SCOTT DOUGLAS;GREENSPAN, PAUL DAVID;TOMMASI, RUBEN ALBERTO;VAN DUZER, JOHN HENRY
分类号 C07D295/10;C07K5/06;A61K31/277;A61K31/341;A61K31/343;A61K31/365;A61K31/381;A61K31/40;A61K31/4035;A61K31/405;A61K31/41;A61K31/4172;A61K31/423;A61K31/426;A61K31/428;A61K31/437;A61K31/44;A61K31/4406;A61K31/4409;A61P9/10;A61P11/06;A61P11/08;A61P19/02;A61P19/10;A61P29/00;A61P31/00;A61P35/00;A61P35/04;A61P37/02;A61P43/00;C07C255/29;C07C255/58;C07C311/19;C07D209/08;C07D209/18;C07D209/20;C07D209/46;C07D209/48;C07D213/56;C07D213/79;C07D233/54;C07D233/64;C07D257/04;C07D263/58;C07D277/20;C07D277/30;C07D277/56;C07D277/62;C07D295/192;C07D307/54;C07D307/56;C07D307/68;C07D307/79;C07D307/88;C07D333/24;C07D333/36;C07D333/38;C07D333/40;C07D333/60;C07D405/12;C07D409/12;C07D471/04 主分类号 C07D295/10
代理机构 代理人
主权项
地址